Women are disproportionately affected by sexually transmitted infections (STIs) throughout
life. In addition to their high prevalence in women, STIs have debilitating effects on female …

Background Data on carcinogenicity of human papillomavirus (HPV) types in the anus are
needed to inform anal cancer prevention through vaccination and screening. This is …

Certain population groups are known to have higher than average anal cancer risk, namely
persons living with HIV (PLHIV), men who have sex with men (MSM), women diagnosed …

Background Monitoring cancer risk among HIV-infected people in the modern antiretroviral
therapy (ART) era is essential given their elevated risk for many cancers and prolonged …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Background Non-AIDS-defining cancers (NADCs) are now becoming a rising cause of
morbidity among people living with HIV (PLHIV) in the highly active antiretroviral therapy …

Background: Previous studies have reported rapid increases in anal cancer incidence rates
in seven high-income countries in North America, Europe and Oceania. There is very limited …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Background: Cancer is increasingly common among persons with HIV. Objective: To
examine calendar trends in cumulative cancer incidence and hazard rate by HIV status …

Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …